Open Access Pre-publication history

Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin

Hidenori Toyoda, Takashi Kumada*, Noritomo Shimada, Koichi Takaguchi, Tatsuya Ide, Michio Sata, Hiroyuki Ginba, Kazuhiro Matsuyama and Namiki Izumi

BMC Infectious Diseases 2012, 12:324  doi:10.1186/1471-2334-12-324

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 02 Aug 2012
Reviewer's Report Norio Akuta 30 Aug 2012
Reviewer's Report Akihito Tsubota 31 Aug 2012
Resubmission - Version 2 Manuscript Author's comment 26 Sep 2012
Resubmission - Version 3 Manuscript Author's comment 16 Oct 2012
Resubmission - Version 4 Manuscript Author's comment 26 Oct 2012
Editorial acceptance 17 Nov 2012
Published 27 Nov 2012